Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Study of Hyperthyroidism in Children
Sponsor: Shengjing Hospital
Summary
This study intends to conduct a retrospective and prospective study on children with hyperthyroidism, and it is a non-intervention study to collect information on diagnosis and treatment and long-term follow-up of children with hyperthyroidism. To investigate the clinical characteristics, treatment effect, side effects and remission of hyperthyroidism in children, to analyze the predictive factors for the effect of antithyroid drug treatment, remission and recurrence after drug withdrawal, and to explore the risk factors related to the occurrence of antithyroid drug-related adverse reactions.
Official title: A Retrospective and Prospective Observational Study of Hyperthyroidism in Children
Key Details
Gender
All
Age Range
29 Days - 14 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2023-07-18
Completion Date
2027-12
Last Updated
2024-08-27
Healthy Volunteers
No
Conditions
Interventions
Methimazole(MMI)
The initial dose of methimazole was 0.2-0.8 mg/(kg▪d). This dose was subsequently reduced by 25% to 50% and adjusted to maintain euthyroidism, based on the results of serum thyroid hormone testing during follow-up.
Locations (1)
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China